Page last updated: 2024-09-05

erlotinib hydrochloride and citric acid, anhydrous

erlotinib hydrochloride has been researched along with citric acid, anhydrous in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)
Trials
(erlotinib hydrochloride)
Recent Studies (post-2010)
(erlotinib hydrochloride)
Studies
(citric acid, anhydrous)
Trials
(citric acid, anhydrous)
Recent Studies (post-2010) (citric acid, anhydrous)
4,3537863,03311,8947834,366

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)citric acid, anhydrous (IC50)
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
perilipin-5Homo sapiens (human)4.5885
perilipin-1Homo sapiens (human)3.708
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)4.5885

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kwiatek, WM; Oćwieja, M; Paluszkiewicz, C; Piergies, N1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and citric acid, anhydrous

ArticleYear
Spectroscopic insights into the effect of pH, temperature, and stabilizer on erlotinib adsorption behavior onto Ag nanosurface.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2020, Mar-05, Volume: 228

    Topics: Antineoplastic Agents; Citric Acid; Erlotinib Hydrochloride; Hydrogen-Ion Concentration; Metal Nanoparticles; Models, Molecular; Silver; Spectrum Analysis, Raman; Temperature

2020